Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Revenue | 339.22 | 304.22 | 281.21 | 250.53 |
Total Revenue | 339.22 | 304.22 | 281.21 | 250.53 |
Costof Revenue Total | 191.75 | 172.77 | 167.53 | 150.95 |
Gross Profit | 147.47 | 131.45 | 113.69 | 99.58 |
Selling/ General/ Admin Expenses Total | 60.38 | 55.30 | 47.25 | 41.88 |
Depreciation/ Amortization | 10.07 | 9.13 | 9.04 | 9.52 |
Other Operating Expenses Total | 55.56 | 51.03 | 42.96 | 33.25 |
Total Operating Expense | 317.76 | 288.22 | 266.78 | 235.59 |
Operating Income | 21.46 | 15.99 | 14.44 | 14.94 |
Interest Inc( Exp) Net- Non- Op Total | -152.58 | -100.57 | -85.08 | -105.39 |
Other Net | 2.85 | -1.23 | 3.25 | -0.30 |
Net Income Before Taxes | 9.05 | 4.75 | 9.18 | 4.10 |
Provisionfor Income Taxes | 1.60 | 2.13 | 3.48 | -0.61 |
Net Income After Taxes | 7.45 | 2.62 | 5.71 | 4.71 |
Minority Interest | -0.05 | -0.05 | -0.09 | 0.03 |
Net Income Before Extra Items | 7.39 | 2.57 | 5.61 | 4.74 |
Net Income | 7.39 | 2.57 | 5.61 | 4.74 |
Total Adjustmentsto Net Income | 0.00 | - | 0.00 | - |
Income Availableto Com Excl Extra Ord | 7.39 | 2.57 | 5.61 | 4.74 |
Income Availableto Com Incl Extra Ord | 7.39 | 2.57 | 5.61 | 4.74 |
Diluted Net Income | 7.39 | 2.57 | 5.61 | 4.74 |
Diluted Weighted Average Shares | 1.58 | 1.57 | 1.51 | 1.42 |
Diluted EPS Excluding Extra Ord Items | 4.68 | 1.64 | 3.71 | 3.34 |
DPS- Common Stock Primary Issue | 1.20 | 1.00 | 1.00 | 1.00 |
Diluted Normalized EPS | 4.68 | 1.63 | 3.71 | 3.34 |
Gain( Loss)on Saleof Assets | - | 0.39 | - | - |
Bal Pharma Dividend Bal Pharma Bonus Bal Pharma News Bal Pharma AGM Bal Pharma Rights Bal Pharma Splits Bal Pharma Board Meetings Bal Pharma Key Metrics Bal Pharma Shareholdings Bal Pharma Balance Sheet Bal Pharma Cashflow Bal Pharma Q1 Results Bal Pharma Q2 Results Bal Pharma Q3 Results Bal Pharma Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks